United States Market for Rheumatoid Arthritis Pharmacotherapeutics

Changes on the Horizon with the Imminent Arrival of Novel Therapies

Regular Price: USD 4,950.00

Special Price USD 3,712.50

25% OFF

* Required Fields

Regular Price: USD 4,950.00

Special Price USD 3,712.50


Be the first to review this product

This research service covers the United States rheumatoid arthritis pharmaceuticals market from 2009 to 2017, with 2011 as the base year. The focus of this study is prescription therapeutics prescribed used on top of background standard of care. Included in the study are products of the market and products in development, as well as patient and revenue forecasts. Market challenges, drivers, and restraints are identified and assessed. Treatment paradigms for rheumatoid arthritis and patient flow dynamics through lines of therapy are also included. The market is segmented by classes of drug: tumor necrosis factor (TNF) inhibitors, non-TNF biologics, and novel oral disease-modifying antirheumatic drugs (DMARDs).

Table of Contents

United States Market for Rheumatoid Arthritis Pharmacotherapeutics, Rheumatoid Arthritis Pharmacotherapeutics MarketResearch ServiceExecutive SummaryMarket OverviewTotal Rheumatoid Arthritis Pharmacotherapeutics MarketExternal Challenges: Drivers and RestraintsForecasts and TrendsDemand AnalysisMarket Share and Competitive AnalysisUnited States Market for Rheumatoid Arthritis Pharmacotherapeutics—Analysis by Market SegmentTNF Inhibitor Segment BreakdownNon-TNF Biologics Segment BreakdownNovel Oral DMARDs Segment BreakdownThe Last WordThree Big PredictionsAppendixAppendix

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.